+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Enteric Disease Testing Market by Product, Disease Type, Diagnostic Techniques, Testing Site - Global Forecast 2025-2030- Product Image
Enteric Disease Testing Market by Product, Disease Type, Diagnostic Techniques, Testing Site - Global Forecast 2025-2030- Product Image
Sale

Enteric Disease Testing Market by Product, Disease Type, Diagnostic Techniques, Testing Site - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5674144
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Enteric Disease Testing Market grew from USD 4.31 billion in 2023 to USD 4.54 billion in 2024. It is expected to continue growing at a CAGR of 5.47%, reaching USD 6.26 billion by 2030.

Enteric disease testing encompasses the diagnosis and analysis of infections affecting the gastrointestinal tract, typically caused by bacteria, viruses, or parasites. It is crucial for public health to control outbreaks and improve patient outcomes. The application of enteric disease testing spans clinical laboratories, hospitals, and public health sectors, ensuring the quality of food and water sources and promptly diagnosing person-to-person transmissible diseases. End-use scopes include hospitals, diagnostic centers, and research institutes. Market growth is propelled by rising incidences of enteric diseases, heightened awareness of healthcare, and technological advancements in diagnostic tools, like multiplex PCR and next-generation sequencing. Currently, potential opportunities lie in the development of rapid, accurate tests that can be deployed in various settings, from elaborate lab environments to point-of-care testing in remote areas. Investment in AI-based diagnostic technologies can also streamline test processes and enhance accuracy, particularly in regions lacking infrastructure.

However, the market faces challenges such as the high cost of advanced testing equipment and the need for technically skilled personnel. Variations in regulatory frameworks across regions can also slow market penetration. Budget constraints in low-income countries further impede the widespread adoption of contemporary testing methodologies. Despite these limitations, innovation-for-growth opportunities exist in the enhancement of telemedicine services to provide remote consultation and monitoring, expansion of mobile health platforms that utilize real-time data, and investment in biodegradable diagnostic materials to lessen the environmental impact of widespread testing. The nature of the enteric disease testing market is dynamic, with continuous innovations and varying demand across geographies influencing growth patterns. Companies that leverage data analytics for market trends and invest in eco-friendly technologies could gain a competitive edge. By focusing on affordable testing solutions and public-private partnerships, businesses can address current market restraints while fostering sustainable growth.

Understanding Market Dynamics in the Enteric Disease Testing Market

The Enteric Disease Testing Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising prevalence of enteric diseases due to poor sanitation and contaminated water supplies
    • Technological innovations in diagnostic tests offer greater sensitivity, specificity, and faster results
    • Governmental and non-governmental organizations' initiatives to control infectious diseases
  • Market Restraints
    • High cost of advanced tests and the lack of infrastructure in emerging countries
  • Market Opportunities
    • Increasing investment in healthcare infrastructure and the focus on preventive diagnostics
    • Strategic partnerships and collaborations for R&D activities and market expansion
  • Market Challenges
    • Regulations concerning the approval and commercialization of product

Exploring Porter’s Five Forces for the Enteric Disease Testing Market

Porter’s Five Forces framework further strengthens the insights of the Enteric Disease Testing Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Enteric Disease Testing Market

External macro-environmental factors deeply influence the performance of the Enteric Disease Testing Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Enteric Disease Testing Market

The Enteric Disease Testing Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Enteric Disease Testing Market

The Enteric Disease Testing Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Enteric Disease Testing Market

The Enteric Disease Testing Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Enteric Disease Testing Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Als Limited, Asure Quality, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biomerica Inc., bioMérieux SA, Bureau Veritas Group, Cepheid Inc., Coris BioConcept SPRL, DiaSorin, Eurofins Scientific SE, Hardy Diagnostics, Intertek Group PLC, Merck & Co., Inc., Merck KGAA, Meridian Bioscience Inc., Mérieux NutriSciences Corporation, Neogen Corporation, Nova Biologicals, Perkinelmer, Inc., Qiagen N.V., Quest Diagnostics, Romer Labs Division Holding GmbH, SGS SA, Symbio Laboratories, Thermo Fisher Scientific Inc., Trinity Biotech PLC, and TÜV SÜD AG.

Market Segmentation & Coverage

This research report categorizes the Enteric Disease Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Consumables
    • Kits
    • Reagents
  • Disease Type
    • Bacterial
      • Cholera
      • Escherichia coli
      • Salmonellosis
    • Parasitic
    • Viral
  • Diagnostic Techniques
    • Immunoassays
    • Molecular Diagnostics
      • PCR
      • Real-time PCR
    • Rapid Diagnostics
      • Dipsticks
      • Lateral Flow Assays
  • Testing Site
    • In-Hospital
    • Point-of-Care
    • Standalone Laboratories
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of enteric diseases due to poor sanitation and contaminated water supplies
5.1.1.2. Technological innovations in diagnostic tests offer greater sensitivity, specificity, and faster results
5.1.1.3. Governmental and non-governmental organizations' initiatives to control infectious diseases
5.1.2. Restraints
5.1.2.1. High cost of advanced tests and the lack of infrastructure in emerging countries
5.1.3. Opportunities
5.1.3.1. Increasing investment in healthcare infrastructure and the focus on preventive diagnostics
5.1.3.2. Strategic partnerships and collaborations for R&D activities and market expansion
5.1.4. Challenges
5.1.4.1. Regulations concerning the approval and commercialization of product
5.2. Market Segmentation Analysis
5.2.1. Disease Type: Increasing preference for multiplex and molecular diagnostic methods for bacterial testing
5.2.2. Testing Site: Need for rapid diagnostics crucial for immediate patient care in hospitals
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Enteric Disease Testing Market, by Product
6.1. Introduction
6.2. Consumables
6.3. Kits
6.4. Reagents
7. Enteric Disease Testing Market, by Disease Type
7.1. Introduction
7.2. Bacterial
7.2.1. Cholera
7.2.2. Escherichia coli
7.2.3. Salmonellosis
7.3. Parasitic
7.4. Viral
8. Enteric Disease Testing Market, by Diagnostic Techniques
8.1. Introduction
8.2. Immunoassays
8.3. Molecular Diagnostics
8.3.1. PCR
8.3.2. Real-time PCR
8.4. Rapid Diagnostics
8.4.1. Dipsticks
8.4.2. Lateral Flow Assays
9. Enteric Disease Testing Market, by Testing Site
9.1. Introduction
9.2. In-Hospital
9.3. Point-of-Care
9.4. Standalone Laboratories
10. Americas Enteric Disease Testing Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Enteric Disease Testing Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Enteric Disease Testing Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. FDA Clears MeMed BV Direct from Whole Blood
13.3.2. Avacta Acquires European Diagnostic Test Maker
13.3.3. Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. ENTERIC DISEASE TESTING MARKET RESEARCH PROCESS
FIGURE 2. ENTERIC DISEASE TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2023 VS 2030 (%)
FIGURE 11. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2023 VS 2030 (%)
FIGURE 13. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. ENTERIC DISEASE TESTING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. ENTERIC DISEASE TESTING MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. ENTERIC DISEASE TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. ENTERIC DISEASE TESTING MARKET DYNAMICS
TABLE 7. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY CHOLERA, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY ESCHERICHIA COLI, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY SALMONELLOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PARASITIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY VIRAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DIPSTICKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY IN-HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY POINT-OF-CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY STANDALONE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 55. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 57. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 58. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 59. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 60. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 61. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 62. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 64. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 65. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 66. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 67. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 68. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 85. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 87. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 88. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 89. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 90. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 91. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 92. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 93. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 94. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 95. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 96. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 97. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 98. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 99. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 101. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 102. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 103. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 104. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 105. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 106. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 108. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 109. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 110. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 111. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 112. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 113. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 115. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 116. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 117. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 118. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 119. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 120. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 121. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 122. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 123. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 124. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 125. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 126. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 127. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 128. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 129. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 130. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 131. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 132. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 133. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 134. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 136. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 137. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 138. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 139. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 140. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 141. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 142. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 143. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 144. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 145. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 146. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 147. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 148. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 149. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 150. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 151. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 152. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 153. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 154. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 155. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 156. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 157. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 158. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 159. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 160. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 161. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 162. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 164. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 165. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 166. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 167. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 168. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 177. DENMARK ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 178. DENMARK ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 179. DENMARK ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 180. DENMARK ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 181. DENMARK ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 182. DENMARK ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 183. DENMARK ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 184. EGYPT ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 185. EGYPT ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 186. EGYPT ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 187. EGYPT ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 188. EGYPT ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 189. EGYPT ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 190. EGYPT ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 191. FINLAND ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 192. FINLAND ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 193. FINLAND ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 194. FINLAND ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 195. FINLAND ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 196. FINLAND ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 197. FINLAND ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 198. FRANCE ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 199. FRANCE ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 200. FRANCE ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 201. FRANCE ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 202. FRANCE ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 203. FRANCE ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 204. FRANCE ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 205. GERMANY ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 206. GERMANY ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 207. GERMANY ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 208. GERMANY ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 209. GERMANY ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 210. GERMANY ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 211. GERMANY ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 212. ISRAEL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 213. ISRAEL ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 214. ISRAEL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 215. ISRAEL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 216. ISRAEL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 217. ISRAEL ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 218. ISRAEL ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 219. ITALY ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 220. ITALY ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 221. ITALY ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 222. ITALY ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 223. ITALY ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 224. ITALY ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 225. ITALY ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 226. NETHERLANDS ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 227. NETHERLANDS ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 228. NETHERLANDS ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 229. NETHERLANDS ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 230. NETHERLANDS ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 231. NETHERLANDS ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 232. NETHERLANDS ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 233. NIGERIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 234. NIGERIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 240. NORWAY ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 241. NORWAY ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 242. NORWAY ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 243. NORWAY ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 244. NORWAY ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 245. NORWAY ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 246. NORWAY ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 247. POLAND ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 248. POLAND ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 249. POLAND ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 250. POLAND ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 251. POLAND ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 252. POLAND ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 253. POLAND ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 254. QATAR ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 255. QATAR ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 256. QATAR ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 257. QATAR ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 258. QATAR ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 259. QATAR ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 260. QATAR ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 261. RUSSIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 262. RUSSIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 263. RUSSIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 268. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 270. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 276. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 278. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 282. SPAIN ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 283. SPAIN ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 284. SPAIN ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 285. SPAIN ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 286. SPAIN ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 287. SPAIN ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 288. SPAIN ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 289. SWEDEN ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 290. SWEDEN ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 291. SWEDEN ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 292. SWEDEN ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 293. SWEDEN ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 294. SWEDEN ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 296. SWITZERLAND ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 297. SWITZERLAND ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 298. SWITZERLAND ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 299. SWITZERLAND ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 300. SWITZERLAND ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 301. SWITZERLAND ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 302. SWITZERLAND ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 303. TURKEY ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 304. TURKEY ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 305. TURKEY ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 306. TURKEY ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 307. TURKEY ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 308. TURKEY ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 309. TURKEY ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 310. UNITED ARAB EMIRATES ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 311. UNITED ARAB EMIRATES ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 312. UNITED ARAB EMIRATES ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 317. UNITED KINGDOM ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 318. UNITED KINGDOM ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 319. UNITED KINGDOM ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 320. UNITED KINGDOM ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 321. UNITED KINGDOM ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 322. UNITED KINGDOM ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 323. UNITED KINGDOM ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 324. ENTERIC DISEASE TESTING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 325. ENTERIC DISEASE TESTING MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Enteric Disease Testing market, which are profiled in this report, include:
  • 3M Company
  • Abbott Laboratories
  • Als Limited
  • Asure Quality
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biomerica Inc.
  • bioMérieux SA
  • Bureau Veritas Group
  • Cepheid Inc.
  • Coris BioConcept SPRL
  • DiaSorin
  • Eurofins Scientific SE
  • Hardy Diagnostics
  • Intertek Group PLC
  • Merck & Co., Inc.
  • Merck KGAA
  • Meridian Bioscience Inc.
  • Mérieux NutriSciences Corporation
  • Neogen Corporation
  • Nova Biologicals
  • Perkinelmer, Inc.
  • Qiagen N.V.
  • Quest Diagnostics
  • Romer Labs Division Holding GmbH
  • SGS SA
  • Symbio Laboratories
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech PLC
  • TÜV SÜD AG

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages182
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 4.54 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.26 Billion
Compound Annual Growth Rate5.4%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

Enteric Disease Testing - Global Strategic Business Report - Product Image

Enteric Disease Testing - Global Strategic Business Report

  • Report
  • 158 Pages
  • Global
From
Enteric Disease Testing Market Report by Product Type, Technique, Disease Type, End User, and Region 2024-2032 - Product Image

Enteric Disease Testing Market Report by Product Type, Technique, Disease Type, End User, and Region 2024-2032

  • Report
  • 143 Pages
  • Global
From
Enteric Disease Testing Global Market Report 2024 - Product Image

Enteric Disease Testing Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Enteric Disease Testing Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Enteric Disease Testing Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Enteric Disease Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Enteric Disease Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 184 Pages
  • Global
From

About the Enteric Disease Diagnostic Market

The Enteric Disease Diagnostic market is a subset of the Diagnostics industry, focusing on the detection and diagnosis of diseases of the gastrointestinal tract. These diseases can be caused by a variety of pathogens, including bacteria, viruses, and parasites. Diagnostic tests are used to identify the presence of these pathogens, as well as to monitor the effectiveness of treatments. Tests may include stool sample analysis, serology, and molecular diagnostics. Enteric Disease Diagnostics are used in both clinical and research settings, and are important for the prevention and control of infectious diseases. They are also used to monitor the safety of food and water supplies. Companies in the Enteric Disease Diagnostic market include Bio-Rad Laboratories, Becton Dickinson, Cepheid, Hologic, and Luminex. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.